ArticleArthritis research & therapy2010

Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.

Jean-Luc Davignon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.